Literature DB >> 33363091

The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China.

Baojing Li1,2, Hong Tang1,2, Zilu Cheng3, Yuxiao Zhang1,2, Hao Xiang1,2.   

Abstract

Leukemia is one of the most common cancers. We conducted this study to comprehensively analyze the temporal trends of leukemia mortality during 2003-2017 and project the trends until 2030. We extracted national-level data on annual leukemia mortality from China Health Statistics Yearbooks (2003-2017). We applied the Joinpoint regression model to assess leukemia mortality trends in urban and rural China by sex during 2003-2017. We also produced sex-specific leukemia mortality using the adjusted Global Burden Disease (GBD) 2016 projection model. In urban areas, age-standardized leukemia mortality decreased significantly among females during 2003-2017 (APC = -0.9%; 95% CI: -1.7, -0.1%). In rural areas, significant decreases of age-standardized leukemia mortality were both found among males (APC = -1.7%; 95% CI: -2.9, -0.5%) and females (APC = -1.6%; 95% CI: -2.6, -0.7%) from 2008 to 2017. Rural-urban and sex disparities of leukemia mortality will continue to exist until the year 2030. According to projection, the leukemia mortality rates of males and rural populations are higher than that of females and urban populations. In 2030, leukemia mortality is projected to decrease to 3.03/100,000 and 3.33/100,000 among the males in urban and rural areas, respectively. In females, leukemia mortality will decrease to 1.87/100,000 and 2.26/100,000 among urban and rural areas, respectively. Our study suggests that more precautionary measures to reduce leukemia mortality are need, and more attention should be paid to rural residents and males in primary prevention of leukemia in China.
Copyright © 2020 Li, Tang, Cheng, Zhang and Xiang.

Entities:  

Keywords:  SDGs; joinpoint analysis; leukemia; mortality; projection

Mesh:

Year:  2020        PMID: 33363091      PMCID: PMC7759534          DOI: 10.3389/fpubh.2020.598215

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  39 in total

1.  Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.

Authors:  Yihuang Wang; Limin Zhang; Wen-Lian Chen; Jing-Han Wang; Ning Li; Jun-Min Li; Jian-Qing Mi; Wei-Na Zhang; Yang Li; Song-Fang Wu; Jie Jin; Yun-Gui Wang; He Huang; Zhu Chen; Sai-Juan Chen; Huiru Tang
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

Review 2.  Avoided and avoidable risks of cancer.

Authors:  L Tomatis; J Huff; I Hertz-Picciotto; D P Sandler; J Bucher; P Boffetta; O Axelson; A Blair; J Taylor; L Stayner; J C Barrett
Journal:  Carcinogenesis       Date:  1997-01       Impact factor: 4.944

Review 3.  Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.

Authors:  Hagop Kantarjian; Susan O'Brien; Elias Jabbour; Gisoo Barnes; Ashutosh Pathak; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-10-05

Review 4.  Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis.

Authors:  Abdul Khalade; Maritta S Jaakkola; Eero Pukkala; Jouni J K Jaakkola
Journal:  Environ Health       Date:  2010-06-28       Impact factor: 5.984

Review 5.  Chronic myelogenous leukemia and benzene exposure: a systematic review and meta-analysis of the case-control literature.

Authors:  Steven H Lamm; Arnold Engel; Kiran P Joshi; Daniel M Byrd; Rusan Chen
Journal:  Chem Biol Interact       Date:  2009-08-18       Impact factor: 5.192

6.  A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

Authors:  Wen-Lian Chen; Jing-Han Wang; Ai-Hua Zhao; Xin Xu; Yi-Huang Wang; Tian-Lu Chen; Jun-Min Li; Jian-Qing Mi; Yong-Mei Zhu; Yuan-Fang Liu; Yue-Ying Wang; Jie Jin; He Huang; De-Pei Wu; Yan Li; Xiao-Jing Yan; Jin-Song Yan; Jian-Yong Li; Shuai Wang; Xiao-Jun Huang; Bing-Shun Wang; Zhu Chen; Sai-Juan Chen; Wei Jia
Journal:  Blood       Date:  2014-07-08       Impact factor: 22.113

7.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

8.  Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil.

Authors:  Fernando Callera; Alexandra Fernandes Callera; Evandro Secchi Rosa
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-21

9.  The political economy of results-based financing: the experience of the health system in Zimbabwe.

Authors:  Sophie Witter; Yotamu Chirwa; Pamela Chandiwana; Shungu Munyati; Mildred Pepukai; Maria Paola Bertone
Journal:  Glob Health Res Policy       Date:  2019-07-15

10.  Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study.

Authors:  Jennifer A Rusiecki; Rahulkumar Patel; Stella Koutros; Laura Beane-Freeman; Ola Landgren; Matthew R Bonner; Joseph Coble; Jay Lubin; Aaron Blair; Jane A Hoppin; Michael C R Alavanja
Journal:  Environ Health Perspect       Date:  2008-11-10       Impact factor: 9.031

View more
  4 in total

1.  Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells.

Authors:  Xiaobin Wang; Xiaoyu Liu; Huihan Wang
Journal:  Cancer Gene Ther       Date:  2022-06-29       Impact factor: 5.987

2.  Acute lymphocytic leukemia severity and mortality hospitalizations in the United States: A population-based study.

Authors:  Saanie Sulley; Saka Abimbola; Memory Ndanga
Journal:  Int J Health Sci (Qassim)       Date:  2022 May-Jun

3.  Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.

Authors:  Yang Ou; Yichen Long; Lili Ji; Yanxia Zhan; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

4.  Cancer Burden in China during 1990-2019: Analysis of the Global Burden of Disease.

Authors:  Shu-Zhen Zhang; Li Zhang; Long Xie
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.